Obstructive Sleep Apnea
Conditions
Keywords
obstructive sleep apnea, upper airway stimulation therapy
Brief summary
Upper airway stimulation (UAS) via unilateral implantation of a phasic hypoglossal nerve stimulation device is a safe and effective alternative treatment for patients with moderate to severe obstructive sleep apnea (OSA) who are unwilling or unable to adhere to positive airway pressure (PAP) therapy. Although adherence to UAS is higher than to PAP, there remain patients who are not using UAS consistently. The aim of this project is to explore critical factors in the use of UAS by OSA patients using qualitative research methods (personal interviews). The proposed study will provide crucial information about patients' concerns regarding UAS use and suggestions for how to support new UAS recipients.
Interventions
DEVICEUpper airway stimulation (Inspire Medical Systems, Inc.)
phasic hypoglossal nerve stimulation device
Sponsors
Inspire Medical Systems, Inc.
University of Pittsburgh
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* 18 years of age and older * ADHERE registry patient * Received UAS implant from June 2017 to present
Exclusion criteria
* Patients without up to date contact information
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Experiences with UAS therapy | up to 4 years | individual qualitative interview via telephone |
Countries
United States
Outcome results
None listed